[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619724":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":7,"responsibleParty":28,"collaborators":30,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":58,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":7},{"fullName":5,"class":6},"Ceric Sàrl","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","Excimer Laser Coronary Atherectomy (ELCA)","ELCA treat a significant coronary stenosis or recanalize occluded coronary arteries using UV during percutaneous coronary intervention.",[14],{"name":15,"affiliation":16,"role":17},"Peter O'kane, Professor","Dorset Heart Centre, The Royal Bournemouth Hospital","STUDY_CHAIR",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Julie FAURE","CONTACT","+33 (0)675574485","jfaure@cerc-europe.org",{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},"Phani Kondamudi","+33 (0)6 60 05 55 12","pkondamudi@cerc-europe.org",{"type":29,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[31,33],{"name":32,"class":6},"Philips Medical Systems",{"name":34,"class":35},"European Cardiovascular Research Center","NETWORK","100619724","coronary-laser-atherectomy-registry-from-an-international-taskforce-100619724",false,"NCT07348341","Coronary Laser Atherectomy Registry From an International Taskforce","CLARIT","Inclusion Criteria:\n\nSubjects will be included if all the following criteria are met:\n\n1. Age 18 years or over\n2. Patient willing to be included in the registry\n3. Patients with stable coronary artery disease or acute coronary syndromes with de-novo or intra-stent restenosis (ISR) coronary lesions suitable to be treated with ELCA\n\n   * Non-Crossable with ICI catheter or:\n   * Crossable with ICI catheter with significant calcium score suggesting need for calcium modification based on IVUS or OCT criteria and\u002For\n   * Non-Dilatable with 1:1 NC balloon\n4. Mandated use of ICI:\n\n   * Attempted before use of ELCA or\n   * Following ELCA and any other calcium modification strategy utilized (to evaluate whether the additional modification demonstrates significant additional modification of the calcium on ICI)\n   * Final after DES implantation or prior to use of DCB\n5. Declared PCI strategy (planned use of ELCA, need for IVL\u002Fspecialty balloons\u002Falternative atherectomy and stent strategy) prior to PCI procedure\n\nExclusion Criteria:\n\n1. Pregnant or breast feeding\n2. Unable to give informed consent\n3. PCI performed without IVCI attempt\n4. No ELCA use\n5. Allergy to clopidogrel, prasugrel or ticagrelor or non-compliance\n6. Post- cardiac arrest or haemodynamic instability\n7. Participation in another trial.","ALL","18 Years",{"count":46,"type":47},500,"ESTIMATED","OBSERVATIONAL","This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).",[51,52],"Stable Coronary Artery Disease","Acute Coronary Syndromes",[54,55,41,56,57],"excimer laser coronary atherectomy","ELCA","coronary artery disease","acute coronary syndromes","NOT_YET_RECRUITING","2026-01-08",{"date":61,"type":62},"2026-01-16","ACTUAL",{"date":64,"type":47},"2026-04-30",{"date":66,"type":47},"2029-07-30",{"name":5,"class":6}]